The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 268,769 | 1,985,000 | SH | SOLE | 1,985,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 7,002 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ADICET BIO INC | COM | 007002108 | 53,065 | 3,034,004 | SH | SOLE | 3,034,004 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 62,745 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 31,695 | 2,773,000 | SH | SOLE | 2,773,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 18,628 | 1,345,000 | SH | SOLE | 1,345,000 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 25,327 | 2,765,000 | SH | SOLE | 2,765,000 | 0 | 0 | ||
AMN HEALTHCARE SVCS INC | COM | 001744101 | 34,265 | 280,100 | SH | SOLE | 280,100 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 148,796 | 321,000 | SH | SOLE | 321,000 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 112,969 | 1,215,500 | SH | SOLE | 1,215,500 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 58,013 | 875,000 | SH | SOLE | 875,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 207,648 | 2,527,973 | SH | SOLE | 2,527,973 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 4,958 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 167,014 | 2,867,200 | SH | SOLE | 2,867,200 | 0 | 0 | ||
AVANTOR INC | COM | 05352A100 | 201,935 | 4,792,000 | SH | SOLE | 4,792,000 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 43,143 | 1,815,000 | SH | SOLE | 1,815,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 29,280 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
BAXTER INTL INC | COM | 071813109 | 151,508 | 1,765,000 | SH | SOLE | 1,765,000 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 4,900 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 30,389 | 3,775,000 | SH | SOLE | 3,775,000 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 157,103 | 1,140,000 | SH | SOLE | 1,140,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 106,574 | 995,000 | SH | SOLE | 995,000 | 0 | 0 | ||
CAREMAX INC | COM CL A | 14171W103 | 6,354 | 827,402 | SH | SOLE | 827,402 | 0 | 0 | ||
CARIBOU BIOSCIENCES INC | COM | 142038108 | 40,352 | 2,674,067 | SH | SOLE | 2,674,067 | 0 | 0 | ||
CATALENT INC | COM | 148806102 | 88,981 | 695,000 | SH | SOLE | 695,000 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 13,505 | 851,522 | SH | SOLE | 851,522 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 23,463 | 644,400 | SH | SOLE | 644,400 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 6,340 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 21,029 | 1,849,538 | SH | SOLE | 1,849,538 | 0 | 0 | ||
DEFINITIVE HEALTHCARE CORP | CLASS A COM | 24477E103 | 6,833 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
DYNAMICS SPECIAL PURPOSE COR | CLASS A COM | 268010105 | 4,930 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ENTRADA THERAPEUTICS INC | COM | 29384C108 | 4,366 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
EQRX INC | COM | 26886C107 | 6,820 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 34,932 | 2,460,000 | SH | SOLE | 2,460,000 | 0 | 0 | ||
FIELD TRIP HEALTH LTD | COM | 31656R102 | 7,884 | 3,205,000 | SH | SOLE | 3,205,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 25,231 | 862,000 | SH | SOLE | 862,000 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 8,825 | 710,000 | SH | SOLE | 710,000 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 56,198 | 4,370,000 | SH | SOLE | 4,370,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 4,032 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 3,956 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HOLOGIC INC | COM | 436440101 | 81,460 | 1,064,000 | SH | SOLE | 1,064,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 109,053 | 1,012,000 | SH | SOLE | 1,012,000 | 0 | 0 | ||
HYPERFINE INC | COM CL A | 44916K106 | 10,979 | 1,514,410 | SH | SOLE | 1,514,410 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 60,353 | 2,553,000 | SH | SOLE | 2,553,000 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 42,115 | 1,230,000 | SH | SOLE | 1,230,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 39,498 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
INSTIL BIO INC | COM | 45783C101 | 6,983 | 408,140 | SH | SOLE | 408,140 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 72,160 | 3,780,000 | SH | SOLE | 3,780,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 116,288 | 6,955,000 | SH | SOLE | 6,955,000 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 53,976 | 3,228,200 | SH | SOLE | 3,228,200 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 42,538 | 670,000 | SH | SOLE | 670,000 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 33,182 | 711,900 | SH | SOLE | 711,900 | 0 | 0 | ||
LILLY ELI & CO | COM | 532457108 | 95,241 | 344,800 | SH | SOLE | 344,800 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 42 | 57,770 | SH | SOLE | 57,770 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 5,039 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 3,275 | 103,000 | SH | SOLE | 103,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 118,291 | 806,400 | SH | SOLE | 806,400 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 6,126 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 87,787 | 940,000 | SH | SOLE | 940,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 107,314 | 1,260,000 | SH | SOLE | 1,260,000 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 189 | 99,999 | SH | SOLE | 99,999 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 62,751 | 7,382,488 | SH | SOLE | 7,382,488 | 0 | 0 | ||
ONCOSEC MED INC | COM | 68234L306 | 2,826 | 2,945,000 | SH | SOLE | 2,945,000 | 0 | 0 | ||
ORTHO CLINICAL DIAGNOSTICS H | ORD SHS | G6829J107 | 38,288 | 1,790,000 | SH | SOLE | 1,790,000 | 0 | 0 | ||
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 4,850 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
PFIZER INC | COM | 717081103 | 123,415 | 2,090,000 | SH | SOLE | 2,090,000 | 0 | 0 | ||
PHASEBIO PHARMACEUTICALS INC | COM | 717224109 | 11,497 | 4,405,000 | SH | SOLE | 4,405,000 | 0 | 0 | ||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 37,294 | 1,896,000 | SH | SOLE | 1,896,000 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 16,482 | 731,536 | SH | SOLE | 731,536 | 0 | 0 | ||
SCIENCE 37 HOLDINGS INC | COM | 808644108 | 4,913 | 394,000 | SH | SOLE | 394,000 | 0 | 0 | ||
SCYNEXIS INC | COM NEW | 811292200 | 13,660 | 2,239,278 | SH | SOLE | 2,239,278 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 105,901 | 685,000 | SH | SOLE | 685,000 | 0 | 0 | ||
SEASPINE HLDGS CORP | COM | 81255T108 | 27,376 | 2,010,000 | SH | SOLE | 2,010,000 | 0 | 0 | ||
SEMA4 HOLDINGS CORP | COM CL A | 81663L101 | 4,237 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
SENTINELONE INC | CL A | 81730H109 | 10,502 | 208,000 | SH | SOLE | 208,000 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 1,404 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
SI-BONE INC | COM | 825704109 | 21,930 | 987,400 | SH | SOLE | 987,400 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLD CRPI | CLASS A ORD SHS | G8253W109 | 1,980 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CP | CLASS A ORD SHS | G8253Y105 | 1,964 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253T106 | 1,986 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOCIAL CAP SUVRETTA HLDS CRP | CLASS A ORD SHS | G8253U103 | 1,978 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SOMALOGIC INC | *W EXP 08/31/202 | 83444K113 | 220 | 65,999 | SH | SOLE | 65,999 | 0 | 0 | ||
SOMALOGIC INC | CLASS A COM | 83444K105 | 3,841 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
SOTERA HEALTH CO | COM | 83601L102 | 69,708 | 2,960,000 | SH | SOLE | 2,960,000 | 0 | 0 | ||
STEVANATO GROUP S P A | ORD SHS | T9224W109 | 57,065 | 2,541,893 | SH | SOLE | 2,541,893 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 105,584 | 4,823,400 | SH | SOLE | 4,823,400 | 0 | 0 | ||
TALARIS THERAPEUTICS INC | COM | 87410C104 | 6,958 | 455,037 | SH | SOLE | 455,037 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 7,713 | 705,000 | SH | SOLE | 705,000 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 58,863 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 115,603 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 61,813 | 123,100 | SH | SOLE | 123,100 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 61,488 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 29,309 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 25,271 | 1,278,261 | SH | SOLE | 1,278,261 | 0 | 0 | ||
WEREWOLF THERAPEUTICS INC | COM | 95075A107 | 5,776 | 485,000 | SH | SOLE | 485,000 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 228,223 | 2,715,000 | SH | SOLE | 2,715,000 | 0 | 0 | ||
ZIOPHARM ONCOLOGY INC | COM | 98973P101 | 643 | 590,000 | SH | SOLE | 590,000 | 0 | 0 |